PROGEN

Prostatype Genomics AB (publ)

SE Healthcare Diagnostics & Research

Latest week
10 Jul 2026
Close
0.145500
Fair value
17.882432
Next-week expectancy
Negative 40.84%
Sharemaestro

PROGEN Chart Pack

Prostatype Genomics AB (publ)

Exchange
STO
Latest week
10 Jul 2026
Close
0.145500
Fair value
17.882432
Next-week expectancy
Negative 40.84%
Generated
17 Jul 2026 09:37
Sector
Healthcare
Industry
Diagnostics & Research

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, PROGEN fell 81.58%, moving from 0.79 to 0.15. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -82.56 and has softened across the 12-week window. Market Dynamics is -0.58 on the latest week. Next-week expectancy is negative at 40.84% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.15
12-Week Change
-81.58%
Trend Signal
Inactive
Next-Week Expectancy
Negative 40.84%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-82.56
Market Dynamics
-0.58

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.15
12-Week Change
-81.58%
Trend Signal
Inactive
Next-Week Expectancy
Negative 40.84%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-82.56
Market Dynamics
-0.58

Over the latest 12 completed weeks ending 2026-07-10, PROGEN fell 81.58%, moving from 0.79 to 0.15. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -82.56 and has softened across the 12-week window. Market Dynamics is -0.58 on the latest week. Next-week expectancy is negative at 40.84% based on similar historical setup states.

Industry Peers

Sweden equities in Diagnostics & Research

Stock Exchange Week Open High Low Close Change
IMMNOV Immunovia AB (publ) STO 10 Jul 2026 0.19 0.20 0.19 0.20 1.86%
VIMIAN Vimian Group AB (publ) STO 10 Jul 2026 30.30 31.15 29.60 30.45 0.50%
IDLDX IDL Diagnostics AB (publ) STO 10 Jul 2026 0.42 0.42 0.39 0.42 -0.24%
SENZA SenzaGen AB STO 10 Jul 2026 6.00 6.14 5.40 5.70 -5.00%
SPERM Spermosens AB (publ) STO 10 Jul 2026 0.01 0.01 0.01 0.01 -5.45%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.